Histone deacetylase inhibitors as antidiabetic agents: Advances and opportunities.

Sonthalia, Manisha; Roy, Bhramar Sinha; Chandrawanshi, Divya; Ganesh, Goutham V; Jayasuriya, Ravichandran; Mohandas, Sundhar; Rajagopal, Senthilkumar; Ramkumar, Kunka Mohanram

Sonthalia, Manisha; Roy, Bhramar Sinha; Chandrawanshi, Divya; Ganesh, Goutham V; Jayasuriya, Ravichandran; Mohandas, Sundhar; Rajagopal, Senthilkumar; Ramkumar, Kunka Mohanram.

Afiliación

Sonthalia M; Department of Biotechnology, School of Applied Sciences, REVA University, Bangalore, 560064, India.
Roy BS; Department of Biotechnology, School of Applied Sciences, REVA University, Bangalore, 560064, India.
Chandrawanshi D; Department of Biotechnology, School of Applied Sciences, REVA University, Bangalore, 560064, India.
Ganesh GV; Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, 603 203, Tamil Nadu, India.
Jayasuriya R; Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, 603 203, Tamil Nadu, India.
Mohandas S; Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, 603 203, Tamil Nadu, India.
Rajagopal S; Department of Biotechnology, School of Applied Sciences, REVA University, Bangalore, 560064, India.
Ramkumar KM; Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, 603 203, Tamil Nadu, India. Electronic address: ramkumak@srmist.edu.in.

Eur J Pharmacol ; 935: 175328, 2022 Nov 15.

Article en En | MEDLINE | ID: mdl-36257383

Asunto(s)

Diabetes Mellitus Tipo 2; Células Secretoras de Insulina; Humanos; Inhibidores de Histona Desacetilasas/farmacología; Inhibidores de Histona Desacetilasas/uso terapéutico; Inhibidores de Histona Desacetilasas/metabolismo; Hipoglucemiantes/farmacología; Hipoglucemiantes/uso terapéutico; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Diabetes Mellitus Tipo 2/metabolismo; Histona Desacetilasas/metabolismo; Células Secretoras de Insulina/metabolismo

Palabras clave

Diabetes; HDAC inhibitors; HDACs; Insulin resistance; ß-cell apoptosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina Límite: Humans Idioma: En Revista: Eur J Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google